Search results for "Ameloblastic Carcinoma"

showing 6 items of 6 documents

Combination prosthetic design providing a superior retention for mid-facial defect rehabilitation: A Case Report

2017

Large maxillofacial defects from malignant tumor treatment are rarely rehabilitated by surgical reconstruction alone. Ameloblastic carcinoma, a rare aggressive odontogenic malignant tumor, requires wide surgical excision to gain a tumor-free margin. In the post-surgical defect, prosthetic rehabilitation is the treatment of choice to restore function and esthetics. Moreover, an intra-oral prosthesis such as an obturator restores speech, mastication and deglutition. Retention of the obturator is a major problem while rehabilitating large defects. The existing anatomical structures from the defect with the help of magnet attachments are suitable to enhance retention, stability and support of t…

Prosthetic DentistryRehabilitationbusiness.industrygovernment.form_of_governmentmedicine.medical_treatmentAnatomical structuresDentistryCase Report030206 dentistry:CIENCIAS MÉDICAS [UNESCO]ProsthesisOdontogenic03 medical and health sciencesAmeloblastic carcinoma0302 clinical medicineUNESCO::CIENCIAS MÉDICASFacial defectgovernmentRight posteriorLower borderMedicine030223 otorhinolaryngologybusinessGeneral DentistryJournal of Clinical and Experimental Dentistry
researchProduct

Ameoblastic carcinoma of mandible - A rare case report with review of literature

2010

Ameloblastic carcinoma is a rare malignant lesion with characteristic histologic features and behavior that dictates more aggressive surgical approach than that of a simple ameloblastoma. However, reliable evidence of its biologic activity is currently unavailable due to the scarcity of well-documented cases. It occurs primarily in the mandible in a wide range of age groups; no sex or race predilection has been noted. It may present as a cystic lesion with benign clinical features or as a large tissue mass with ulceration, significant bone resorption and tooth mobility. Because the lesion is usually found unexpectedly after an incisional biopsy or the removal of a cyst, a guide to different…

Pathologymedicine.medical_specialtybusiness.industrygovernment.form_of_governmentOdontología:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludMetastasisLesionAmeloblastic carcinomamedicine.anatomical_structureUNESCO::CIENCIAS MÉDICASCarcinomamedicinegovernmentCystmedicine.symptomDifferential diagnosisAmeloblastomabusinessGeneral DentistryLymph nodeJournal of Clinical and Experimental Dentistry
researchProduct

Expression of caveolin-1 in tooth germ, ameloblastoma and ameloblastic carcinoma

2020

Background The caveolin-1 protein (structural component of membrane caveolae) plays important roles in several biological functions, such as endocytosis, cell adhesion, and cell signaling. However, this protein has been associated with mechanisms of tumorigenesis in several neoplasms. The expression patterns and roles of caveolin-1 in the oral epithelium and in embryonic and odontogenic tumor tissues are still unclear. Material and Methods The expression of caveolin-1 was evaluated in samples of the normal gingival epithelium (n=7), human tooth germ (TG) (n=12), ameloblastoma (AM) (n=83), and ameloblastic carcinoma (AC) (n=9) by immunohistochemistry. Additionally, AM samples were analyzed b…

AdultPathologymedicine.medical_specialtyReal Time Polymerase Chain Reactionrecurrencegovernment.form_of_governmentCaveolin 1Odontogenic TumorsBiologymedicine.disease_causeAmeloblastic CarcinomaMalignant transformationAmeloblastomaWestern blotCaveolin-1medicineHumansCaveolina 1resectionAmeloblastomaGeneral DentistrycurettageUNESCO:CIENCIAS MÉDICASdesmoplastic ameloblastomaOral Medicine and Pathologymedicine.diagnostic_testResearchmixed radiopaque ? radiolucentCarcinomaOdontogenic tumorTooth Germmedicine.diseaseImmunohistochemistryAmeloblastic carcinomaOtorhinolaryngologyCaveolin 1governmentImmunohistochemistrySurgeryCarcinogenesisenucleationMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Stability and marginal bone loss in implants placed using piezoelectric osteotomy versus conventional drilling: systematic review and meta-analysis.

2021

Background The main objective of this systematic review was to compare primary and secondary implant stability between placement with piezoelectric osteotomy and conventional drilling, comparing marginal bone losses as a secondary objective. Material and Methods An electronic search was conducted using PubMed (MEDLINE), Scopus, and Cochrane Library (Wiley) databases, besides a manual search. Results A total of 153 articles were retrieved, 39 from Pubmed, 44 from Scopus, and 70 from the Cochrane Library. After removing duplicates, 112 articles (1 from the manual search) were screened, and 9 were finally selected for qualitative and statistical analyses. Conclusions Piezoelectric surgery is a…

caveolin-1medicine.medical_treatmentameloblastic carcinomareal-time polymerase chain reactioneducationMEDLINEDentistryReviewImplant stabilityCochrane LibraryOsteotomyOsseointegrationameloblastomaOsseointegrationMedicineHumansPiezosurgeryDental implantGeneral DentistryImplant site preparationUNESCO:CIENCIAS MÉDICASPiezoelectric surgeryDental Implantsbusiness.industryMarginal bone lossDental implantsDental Implantation EndosseousImplant stability quotientOsteotomyOtorhinolaryngologyPiezoelectric surgeryimmunohistochemistrySurgeryImplantbusinessImplantologyConventional drillMedicina oral, patologia oral y cirugia bucal
researchProduct

Comparative histological and immunohistochemical study of ameloblastomas and ameloblastic carcinomas

2017

Background This study aimed to compare the histological and immunohistochemical characteristics of ameloblastomas (AM) and ameloblastic carcinomas (AC). Material and Methods Fifteen cases of AM and 9 AC were submitted to hematoxilin and eosin (H&E) and immunohistochemical analysis with the following antibodies: cytokeratins 5,7,8,14 and 19, Ki-67, p53, p63 and the cellular adhesion molecules CD138 (Syndecan-1), E-cadherin and β-catenin. The mean score of the expression of Ki-67 and p53 labelling index (LIs) were compared between the groups using the t test. A value of p<0.05 was considered to be statistically significant. Results All cases were positive for CKs 5, 14 and 19, but negative fo…

tumorsMalePathologyAntibodies Neoplasmameloblastic carcinomaMalignant transformation0302 clinical medicineAmeloblastomaChildp63biologyki-67Middle Aged:CIENCIAS MÉDICAS [UNESCO]ImmunohistochemistryJaw Neoplasms030220 oncology & carcinogenesisKi-67immunohistochemistryUNESCO::CIENCIAS MÉDICASImmunohistochemistry//purl.org/pe-repo/ocde/ford#3.02.11 [https]Femalesyndecan-1 cd138Adultmedicine.medical_specialtyAdolescentgovernment.form_of_governmentcateninMalignancyAmeloblastoma03 medical and health sciencesYoung AdultDentistry Oral Surgery & MedicineexpressionmedicineHumansgeneGeneral DentistryOral Medicine and PathologyCadherinResearchcytokeratinsodontogenic030206 dentistrymedicine.disease//purl.org/pe-repo/ocde/ford#3.02.14 [https]Ameloblastic carcinomaOtorhinolaryngologyCateningovernmentbiology.proteinSurgeryodontogenic-tumorse-cadherin
researchProduct

Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors

2012

Objectives: The aim of this study was to compare among PCNAand Ki-67 as the most reliable immunohisto chemical marker for evaluating cell proliferation in ameloblastic tumors. Study Design: Observational, retrospective, and descriptive study of a large series of ameloblastic tumors, com- D esign: Observational, retrospective, and descriptive study of a large series of ameloblastic tumors, com- esign: Observational, retrospective, and descriptive study of a large series of ameloblastic tumors, com posed of 161 ameloblastomas and four ameloblastic carcinomas, to determine and compare PCNA and Ki-67 expression using immunohistochemistry techniques. Results: When analyzing Ki-67 positivity, the…

Pathologymedicine.medical_specialtyCARCINOMADesmoplastic ameloblastomagovernment.form_of_governmentOdontologíaAmeloblastomaANTIGENO NUCLEAR DE CELULA EN PROLIFERACIONChemical markerCell proliferation markersstomatognathic systemProliferating Cell Nuclear AntigenProliferation ratemedicinePCNAHumansGeneral DentistryCell ProliferationRetrospective StudiesAmeloblastomasOral Medicine and PathologybiologyCell growthbusiness.industry:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludANTIGENO Ki-67Proliferating cell nuclear antigenAmeloblastic carcinomaKi-67 AntigenAMELOBLASTOMAOtorhinolaryngologyKi-67UNESCO::CIENCIAS MÉDICASbiology.proteingovernmentKi-67ImmunohistochemistryResearch-ArticleMouth NeoplasmsSurgerybusinessBiomarkersAmeloblastic carcinoma
researchProduct